Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
<p>Abstract</p> <p>Cardiovascular disease (CVD) risk in type 2 diabetes (T2DM) is only partially reduced by intensive glycemic control. Diabetic dyslipidemia is suggested to be an additional important contributor to CVD risk in T2DM. Multiple lipid lowering medications effectively...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-07-01
|
| Series: | Cardiovascular Diabetology |
| Online Access: | http://www.cardiab.com/content/10/1/61 |